Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative disease

International Journal of Hematology

Volumn 82, Issue 5, 2005, Pages 437-440

  Koyama, Maho ^a,b   Takeshita, Y ^a   Sakata, A ^a   Sawada, A ^a   Yasui, M ^a   Okamura, T ^a   Inoue, M ^a   Kawa, K ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Combination chemotherapy; EBV associated T NK cell LPD; Mosquito allergy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ANAMNESIS; ARTICLE; CASE REPORT; CHEMOTHERAPY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEMALE; HOSPITAL ADMISSION; HUMAN; INSECT ALLERGY; LABORATORY TEST; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MALE; MOSQUITO ALLERGY; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; REMISSION; SEROLOGY; T LYMPHOCYTE; TREATMENT OUTCOME; ALLOTRANSPLANTATION; ANIMAL; IMMEDIATE TYPE HYPERSENSITIVITY; INSECT BITE; METHODOLOGY; MOSQUITO; PATHOLOGY; STEM CELL TRANSPLANTATION; VIROLOGY; VIRUS INFECTION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CULICIDAE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646438720     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05083     Document Type: Article

References (10)

1. Kawa-Ha K, Ishihara S, Ninomiya T, et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest. 1989;84:51-55.
2. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr. 1995;84:1271-1275.
3. Kawa K. Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease. Int J Hematol. 2003; 78:24-31.
4. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98:280-286.
5. Ishihara S, Ohshima K, Tokura Y, et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res. 1997; 88:82-87.
6. Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet. 2000;356:223-224.
7. Taketani T, Kikuchi A, Inatomi J, et al. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002;29:531-533.
8. Okamura T, Kishimoto T, Inoue M, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant. 2003;31:105-111.
9. Kawa K, Okamura T, Yagi K, Takeuchi M, Nakayama M, Inoue M. Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood. 2001;98:3173-3174.
10. + T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Arch Dermatol. 2003;139:1601-1607.